tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
Holding BRNS?
Track your performance easily

Barinthus Biotherapeutics (BRNS) Technical Analysis

87 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Barinthus Biotherapeutics is a Buy.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 1.05, while Barinthus Biotherapeutics’s (BRNS) share price is $0.93, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 1.08, while Barinthus Biotherapeutics’s (BRNS) share price is $0.93, making it a Sell.

Barinthus Biotherapeutics (BRNS) Pivot Points

Jan 29, 2025, 08:15 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.92
0.97
1.02
1.07
1.12
1.17
1.22
Fibonacci
0.97
1.01
1.03
1.07
1.10
1.13
1.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (BRNS) Moving Averages

Jan 29, 2025, 08:15 PM
Period
Simple
Exponential
MA5
1.03Sell
1.03Sell
MA10
1.01Sell
1.04Sell
MA20
1.08Sell
1.05Sell
MA50
1.04Sell
1.08Sell
MA100
1.16Sell
1.20Sell
MA200
1.50Sell
1.57Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 1.04, while Barinthus Biotherapeutics’s (BRNS) share price is $0.93, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 1.20, while Barinthus Biotherapeutics’s (BRNS) share price is $0.93, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.93 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 1.04, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.93 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 1.16, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.93 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 1.50, creating a Sell signal.

Barinthus Biotherapeutics (BRNS) Technical Indicators

Jan 29, 2025, 08:15 PM
Name
Value
Implied Action
RSI (14)
46.81
Neutral
STOCH (9,6)
52.23
Neutral
STOCHRSI (14)
36.77
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
16.53
Buy
Williams %R
-73.17
Buy
CCI (14)
-66.15
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
35.07
Neutral
ROC
-18.55
Sell
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 46.81, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 16.53, creating a Buy signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is -66.15, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is -18.55, creating a Sell signal.

FAQ

Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Strong Sell.
    What is BRNS’s RSI (14)?
    BRNS’s RSI (14) is 46.81, which suggests BRNS is a Neutral.
      What is BRNS’s MACD?
      BRNS’s MACD is -0.01, which suggests BRNS is a Buy.
        What is BRNS’s 5-day moving average?
        BRNS’s 5-day moving average is 1.03, which suggests BRNS is a Sell.
          What is BRNS’s 20-day moving average?
          BRNS 20-day moving average is 1.08, which suggests BRNS is a Sell.
            What is BRNS’s 50-day moving average?
            BRNS’s 50-day moving average is 1.04, which suggests BRNS is a Sell.
              What is BRNS’s 200-day moving average?
              BRNS’s 200-day moving average is 1.50, which suggests BRNS is a Sell.
                What is BRNS’s Williams % R (14)?
                BRNS’s Williams % R (14) is -73.17, which suggests BRNS is a Buy.
                  What is BRNS’s CCI (14)?
                  BRNS’s CCI (14) is -66.15, which suggests BRNS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis